nodes	percent_of_prediction	percent_of_DWPC	metapath
Fosamprenavir—CYP3A4—Ifosfamide—germ cell cancer	0.237	0.498	CbGbCtD
Fosamprenavir—CYP3A4—Vinblastine—germ cell cancer	0.126	0.264	CbGbCtD
Fosamprenavir—CYP3A4—Etoposide—germ cell cancer	0.113	0.238	CbGbCtD
Fosamprenavir—Reaction gastrointestinal—Methotrexate—germ cell cancer	0.0118	0.0226	CcSEcCtD
Fosamprenavir—Osteonecrosis—Methotrexate—germ cell cancer	0.0106	0.0203	CcSEcCtD
Fosamprenavir—Opportunistic infection—Methotrexate—germ cell cancer	0.00981	0.0188	CcSEcCtD
Fosamprenavir—Rhabdomyolysis—Ifosfamide—germ cell cancer	0.00944	0.0181	CcSEcCtD
Fosamprenavir—Inflammation—Ifosfamide—germ cell cancer	0.00861	0.0165	CcSEcCtD
Fosamprenavir—Inflammation—Etoposide—germ cell cancer	0.0068	0.013	CcSEcCtD
Fosamprenavir—Acute coronary syndrome—Vinblastine—germ cell cancer	0.00638	0.0122	CcSEcCtD
Fosamprenavir—Myocardial infarction—Vinblastine—germ cell cancer	0.00635	0.0121	CcSEcCtD
Fosamprenavir—Aspartate aminotransferase increased—Dactinomycin—germ cell cancer	0.00596	0.0114	CcSEcCtD
Fosamprenavir—Haemoglobin—Vinblastine—germ cell cancer	0.00584	0.0112	CcSEcCtD
Fosamprenavir—Haemorrhage—Vinblastine—germ cell cancer	0.00581	0.0111	CcSEcCtD
Fosamprenavir—Acute coronary syndrome—Bleomycin—germ cell cancer	0.00539	0.0103	CcSEcCtD
Fosamprenavir—Myocardial infarction—Bleomycin—germ cell cancer	0.00536	0.0102	CcSEcCtD
Fosamprenavir—Neutropenia—Dactinomycin—germ cell cancer	0.00535	0.0102	CcSEcCtD
Fosamprenavir—Stevens-Johnson syndrome—Dactinomycin—germ cell cancer	0.00506	0.00967	CcSEcCtD
Fosamprenavir—Haemoglobin—Bleomycin—germ cell cancer	0.00493	0.00943	CcSEcCtD
Fosamprenavir—Haemorrhage—Bleomycin—germ cell cancer	0.00491	0.00939	CcSEcCtD
Fosamprenavir—Hyperglycaemia—Ifosfamide—germ cell cancer	0.00473	0.00904	CcSEcCtD
Fosamprenavir—Aspartate aminotransferase increased—Cisplatin—germ cell cancer	0.00471	0.009	CcSEcCtD
Fosamprenavir—Stevens-Johnson syndrome—Ifosfamide—germ cell cancer	0.00463	0.00886	CcSEcCtD
Fosamprenavir—Acute coronary syndrome—Ifosfamide—germ cell cancer	0.00461	0.00881	CcSEcCtD
Fosamprenavir—Myocardial infarction—Ifosfamide—germ cell cancer	0.00458	0.00876	CcSEcCtD
Fosamprenavir—Erythema multiforme—Dactinomycin—germ cell cancer	0.00433	0.00828	CcSEcCtD
Fosamprenavir—Alanine aminotransferase increased—Etoposide—germ cell cancer	0.00423	0.00808	CcSEcCtD
Fosamprenavir—Haemoglobin—Ifosfamide—germ cell cancer	0.00422	0.00806	CcSEcCtD
Fosamprenavir—Haemorrhage—Ifosfamide—germ cell cancer	0.0042	0.00802	CcSEcCtD
Fosamprenavir—Urinary tract disorder—Ifosfamide—germ cell cancer	0.00414	0.00792	CcSEcCtD
Fosamprenavir—Connective tissue disorder—Ifosfamide—germ cell cancer	0.00412	0.00788	CcSEcCtD
Fosamprenavir—Urethral disorder—Ifosfamide—germ cell cancer	0.00411	0.00786	CcSEcCtD
Fosamprenavir—Inflammation—Methotrexate—germ cell cancer	0.00408	0.00779	CcSEcCtD
Fosamprenavir—Acute coronary syndrome—Cisplatin—germ cell cancer	0.00397	0.00759	CcSEcCtD
Fosamprenavir—Erythema multiforme—Ifosfamide—germ cell cancer	0.00397	0.00758	CcSEcCtD
Fosamprenavir—Myocardial infarction—Cisplatin—germ cell cancer	0.00395	0.00755	CcSEcCtD
Fosamprenavir—Anorexia—Vinblastine—germ cell cancer	0.00394	0.00753	CcSEcCtD
Fosamprenavir—Cardiac disorder—Ifosfamide—germ cell cancer	0.00389	0.00744	CcSEcCtD
Fosamprenavir—Neutropenia—Etoposide—germ cell cancer	0.00387	0.0074	CcSEcCtD
Fosamprenavir—Immune system disorder—Ifosfamide—germ cell cancer	0.00379	0.00725	CcSEcCtD
Fosamprenavir—Stevens-Johnson syndrome—Etoposide—germ cell cancer	0.00366	0.007	CcSEcCtD
Fosamprenavir—Malnutrition—Ifosfamide—germ cell cancer	0.00365	0.00698	CcSEcCtD
Fosamprenavir—Acute coronary syndrome—Etoposide—germ cell cancer	0.00364	0.00696	CcSEcCtD
Fosamprenavir—Myalgia—Bleomycin—germ cell cancer	0.00364	0.00696	CcSEcCtD
Fosamprenavir—Myocardial infarction—Etoposide—germ cell cancer	0.00362	0.00692	CcSEcCtD
Fosamprenavir—Decreased appetite—Vinblastine—germ cell cancer	0.00359	0.00686	CcSEcCtD
Fosamprenavir—Urinary tract disorder—Cisplatin—germ cell cancer	0.00357	0.00683	CcSEcCtD
Fosamprenavir—Connective tissue disorder—Cisplatin—germ cell cancer	0.00355	0.0068	CcSEcCtD
Fosamprenavir—Urethral disorder—Cisplatin—germ cell cancer	0.00355	0.00678	CcSEcCtD
Fosamprenavir—Myalgia—Dactinomycin—germ cell cancer	0.00339	0.00649	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Vinblastine—germ cell cancer	0.00338	0.00646	CcSEcCtD
Fosamprenavir—Cardiac disorder—Cisplatin—germ cell cancer	0.00336	0.00642	CcSEcCtD
Fosamprenavir—Angioedema—Ifosfamide—germ cell cancer	0.00334	0.00638	CcSEcCtD
Fosamprenavir—Anorexia—Bleomycin—germ cell cancer	0.00332	0.00636	CcSEcCtD
Fosamprenavir—Diabetes mellitus—Methotrexate—germ cell cancer	0.0033	0.00631	CcSEcCtD
Fosamprenavir—Urinary tract disorder—Etoposide—germ cell cancer	0.00327	0.00626	CcSEcCtD
Fosamprenavir—Immune system disorder—Cisplatin—germ cell cancer	0.00327	0.00625	CcSEcCtD
Fosamprenavir—Abdominal pain—Vinblastine—germ cell cancer	0.00326	0.00624	CcSEcCtD
Fosamprenavir—Urethral disorder—Etoposide—germ cell cancer	0.00325	0.00621	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.00318	0.00608	CcSEcCtD
Fosamprenavir—Malnutrition—Cisplatin—germ cell cancer	0.00315	0.00602	CcSEcCtD
Fosamprenavir—Erythema multiforme—Etoposide—germ cell cancer	0.00313	0.00599	CcSEcCtD
Fosamprenavir—Myalgia—Ifosfamide—germ cell cancer	0.00311	0.00594	CcSEcCtD
Fosamprenavir—Flatulence—Cisplatin—germ cell cancer	0.0031	0.00593	CcSEcCtD
Fosamprenavir—Anorexia—Dactinomycin—germ cell cancer	0.0031	0.00593	CcSEcCtD
Fosamprenavir—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.00309	0.0059	CcSEcCtD
Fosamprenavir—Cardiac disorder—Etoposide—germ cell cancer	0.00308	0.00588	CcSEcCtD
Fosamprenavir—Hypersensitivity—Vinblastine—germ cell cancer	0.00304	0.00582	CcSEcCtD
Fosamprenavir—Decreased appetite—Bleomycin—germ cell cancer	0.00303	0.0058	CcSEcCtD
Fosamprenavir—Immune system disorder—Etoposide—germ cell cancer	0.00299	0.00572	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.00296	0.00567	CcSEcCtD
Fosamprenavir—Asthenia—Vinblastine—germ cell cancer	0.00296	0.00566	CcSEcCtD
Fosamprenavir—Nervous system disorder—Ifosfamide—germ cell cancer	0.00292	0.00559	CcSEcCtD
Fosamprenavir—Skin disorder—Ifosfamide—germ cell cancer	0.0029	0.00554	CcSEcCtD
Fosamprenavir—Anorexia—Ifosfamide—germ cell cancer	0.00284	0.00543	CcSEcCtD
Fosamprenavir—Decreased appetite—Dactinomycin—germ cell cancer	0.00283	0.00541	CcSEcCtD
Fosamprenavir—Diarrhoea—Vinblastine—germ cell cancer	0.00283	0.0054	CcSEcCtD
Fosamprenavir—Fatigue—Dactinomycin—germ cell cancer	0.0028	0.00536	CcSEcCtD
Fosamprenavir—Body temperature increased—Bleomycin—germ cell cancer	0.00276	0.00527	CcSEcCtD
Fosamprenavir—Dizziness—Vinblastine—germ cell cancer	0.00273	0.00522	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.00272	0.00519	CcSEcCtD
Fosamprenavir—Myalgia—Cisplatin—germ cell cancer	0.00268	0.00513	CcSEcCtD
Fosamprenavir—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.00266	0.00509	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.00266	0.00509	CcSEcCtD
Fosamprenavir—Vomiting—Vinblastine—germ cell cancer	0.00263	0.00502	CcSEcCtD
Fosamprenavir—Decreased appetite—Ifosfamide—germ cell cancer	0.00259	0.00495	CcSEcCtD
Fosamprenavir—Headache—Vinblastine—germ cell cancer	0.00259	0.00495	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.00257	0.00492	CcSEcCtD
Fosamprenavir—Body temperature increased—Dactinomycin—germ cell cancer	0.00257	0.00492	CcSEcCtD
Fosamprenavir—Abdominal pain—Dactinomycin—germ cell cancer	0.00257	0.00492	CcSEcCtD
Fosamprenavir—Fatigue—Ifosfamide—germ cell cancer	0.00257	0.00491	CcSEcCtD
Fosamprenavir—Hypersensitivity—Bleomycin—germ cell cancer	0.00257	0.00491	CcSEcCtD
Fosamprenavir—Nervous system disorder—Cisplatin—germ cell cancer	0.00252	0.00482	CcSEcCtD
Fosamprenavir—Asthenia—Bleomycin—germ cell cancer	0.0025	0.00478	CcSEcCtD
Fosamprenavir—Skin disorder—Cisplatin—germ cell cancer	0.0025	0.00477	CcSEcCtD
Fosamprenavir—Pruritus—Bleomycin—germ cell cancer	0.00247	0.00472	CcSEcCtD
Fosamprenavir—Nausea—Vinblastine—germ cell cancer	0.00245	0.00469	CcSEcCtD
Fosamprenavir—Anorexia—Cisplatin—germ cell cancer	0.00245	0.00468	CcSEcCtD
Fosamprenavir—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.00244	0.00466	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.00244	0.00466	CcSEcCtD
Fosamprenavir—Hypersensitivity—Dactinomycin—germ cell cancer	0.0024	0.00458	CcSEcCtD
Fosamprenavir—Abdominal pain—Ifosfamide—germ cell cancer	0.00236	0.00451	CcSEcCtD
Fosamprenavir—Body temperature increased—Ifosfamide—germ cell cancer	0.00236	0.00451	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.00234	0.00448	CcSEcCtD
Fosamprenavir—Asthenia—Dactinomycin—germ cell cancer	0.00233	0.00446	CcSEcCtD
Fosamprenavir—Neutropenia—Methotrexate—germ cell cancer	0.00232	0.00443	CcSEcCtD
Fosamprenavir—Skin disorder—Etoposide—germ cell cancer	0.00229	0.00437	CcSEcCtD
Fosamprenavir—Anorexia—Etoposide—germ cell cancer	0.00224	0.00429	CcSEcCtD
Fosamprenavir—Decreased appetite—Cisplatin—germ cell cancer	0.00223	0.00427	CcSEcCtD
Fosamprenavir—Diarrhoea—Dactinomycin—germ cell cancer	0.00223	0.00426	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.00222	0.00424	CcSEcCtD
Fosamprenavir—Vomiting—Bleomycin—germ cell cancer	0.00222	0.00424	CcSEcCtD
Fosamprenavir—Rash—Bleomycin—germ cell cancer	0.0022	0.0042	CcSEcCtD
Fosamprenavir—Dermatitis—Bleomycin—germ cell cancer	0.0022	0.0042	CcSEcCtD
Fosamprenavir—Hypersensitivity—Ifosfamide—germ cell cancer	0.0022	0.0042	CcSEcCtD
Fosamprenavir—Stevens-Johnson syndrome—Methotrexate—germ cell cancer	0.00219	0.00419	CcSEcCtD
Fosamprenavir—Asthenia—Ifosfamide—germ cell cancer	0.00214	0.00409	CcSEcCtD
Fosamprenavir—Pruritus—Ifosfamide—germ cell cancer	0.00211	0.00403	CcSEcCtD
Fosamprenavir—Nausea—Bleomycin—germ cell cancer	0.00207	0.00396	CcSEcCtD
Fosamprenavir—Vomiting—Dactinomycin—germ cell cancer	0.00207	0.00395	CcSEcCtD
Fosamprenavir—Rash—Dactinomycin—germ cell cancer	0.00205	0.00392	CcSEcCtD
Fosamprenavir—Decreased appetite—Etoposide—germ cell cancer	0.00205	0.00391	CcSEcCtD
Fosamprenavir—Diarrhoea—Ifosfamide—germ cell cancer	0.00204	0.0039	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Etoposide—germ cell cancer	0.00203	0.00389	CcSEcCtD
Fosamprenavir—Body temperature increased—Cisplatin—germ cell cancer	0.00203	0.00388	CcSEcCtD
Fosamprenavir—Fatigue—Etoposide—germ cell cancer	0.00203	0.00388	CcSEcCtD
Fosamprenavir—Haemoglobin—Methotrexate—germ cell cancer	0.002	0.00381	CcSEcCtD
Fosamprenavir—Haemorrhage—Methotrexate—germ cell cancer	0.00199	0.00379	CcSEcCtD
Fosamprenavir—Dizziness—Ifosfamide—germ cell cancer	0.00197	0.00377	CcSEcCtD
Fosamprenavir—Urinary tract disorder—Methotrexate—germ cell cancer	0.00196	0.00375	CcSEcCtD
Fosamprenavir—Urethral disorder—Methotrexate—germ cell cancer	0.00195	0.00372	CcSEcCtD
Fosamprenavir—Nausea—Dactinomycin—germ cell cancer	0.00193	0.00369	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Etoposide—germ cell cancer	0.00193	0.00368	CcSEcCtD
Fosamprenavir—Vomiting—Ifosfamide—germ cell cancer	0.0019	0.00362	CcSEcCtD
Fosamprenavir—Hypersensitivity—Cisplatin—germ cell cancer	0.00189	0.00362	CcSEcCtD
Fosamprenavir—Rash—Ifosfamide—germ cell cancer	0.00188	0.00359	CcSEcCtD
Fosamprenavir—Dermatitis—Ifosfamide—germ cell cancer	0.00188	0.00359	CcSEcCtD
Fosamprenavir—Erythema multiforme—Methotrexate—germ cell cancer	0.00188	0.00359	CcSEcCtD
Fosamprenavir—Body temperature increased—Etoposide—germ cell cancer	0.00186	0.00356	CcSEcCtD
Fosamprenavir—Abdominal pain—Etoposide—germ cell cancer	0.00186	0.00356	CcSEcCtD
Fosamprenavir—Asthenia—Cisplatin—germ cell cancer	0.00184	0.00353	CcSEcCtD
Fosamprenavir—Cardiac disorder—Methotrexate—germ cell cancer	0.00184	0.00352	CcSEcCtD
Fosamprenavir—Immune system disorder—Methotrexate—germ cell cancer	0.00179	0.00343	CcSEcCtD
Fosamprenavir—Nausea—Ifosfamide—germ cell cancer	0.00177	0.00339	CcSEcCtD
Fosamprenavir—Diarrhoea—Cisplatin—germ cell cancer	0.00176	0.00336	CcSEcCtD
Fosamprenavir—Hypersensitivity—Etoposide—germ cell cancer	0.00173	0.00332	CcSEcCtD
Fosamprenavir—Malnutrition—Methotrexate—germ cell cancer	0.00173	0.0033	CcSEcCtD
Fosamprenavir—Asthenia—Etoposide—germ cell cancer	0.00169	0.00323	CcSEcCtD
Fosamprenavir—Pruritus—Etoposide—germ cell cancer	0.00167	0.00318	CcSEcCtD
Fosamprenavir—Vomiting—Cisplatin—germ cell cancer	0.00163	0.00312	CcSEcCtD
Fosamprenavir—Rash—Cisplatin—germ cell cancer	0.00162	0.0031	CcSEcCtD
Fosamprenavir—Dermatitis—Cisplatin—germ cell cancer	0.00162	0.00309	CcSEcCtD
Fosamprenavir—Diarrhoea—Etoposide—germ cell cancer	0.00161	0.00308	CcSEcCtD
Fosamprenavir—Dizziness—Etoposide—germ cell cancer	0.00156	0.00298	CcSEcCtD
Fosamprenavir—Nausea—Cisplatin—germ cell cancer	0.00153	0.00292	CcSEcCtD
Fosamprenavir—Vomiting—Etoposide—germ cell cancer	0.0015	0.00286	CcSEcCtD
Fosamprenavir—Rash—Etoposide—germ cell cancer	0.00148	0.00284	CcSEcCtD
Fosamprenavir—Dermatitis—Etoposide—germ cell cancer	0.00148	0.00284	CcSEcCtD
Fosamprenavir—Headache—Etoposide—germ cell cancer	0.00147	0.00282	CcSEcCtD
Fosamprenavir—Myalgia—Methotrexate—germ cell cancer	0.00147	0.00281	CcSEcCtD
Fosamprenavir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.00146	0.00279	CcSEcCtD
Fosamprenavir—Nausea—Etoposide—germ cell cancer	0.0014	0.00267	CcSEcCtD
Fosamprenavir—Nervous system disorder—Methotrexate—germ cell cancer	0.00138	0.00264	CcSEcCtD
Fosamprenavir—Skin disorder—Methotrexate—germ cell cancer	0.00137	0.00262	CcSEcCtD
Fosamprenavir—Anorexia—Methotrexate—germ cell cancer	0.00134	0.00257	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.00128	0.00246	CcSEcCtD
Fosamprenavir—Decreased appetite—Methotrexate—germ cell cancer	0.00123	0.00234	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.00122	0.00233	CcSEcCtD
Fosamprenavir—Fatigue—Methotrexate—germ cell cancer	0.00122	0.00232	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Methotrexate—germ cell cancer	0.00115	0.0022	CcSEcCtD
Fosamprenavir—Body temperature increased—Methotrexate—germ cell cancer	0.00111	0.00213	CcSEcCtD
Fosamprenavir—Abdominal pain—Methotrexate—germ cell cancer	0.00111	0.00213	CcSEcCtD
Fosamprenavir—Hypersensitivity—Methotrexate—germ cell cancer	0.00104	0.00199	CcSEcCtD
Fosamprenavir—Asthenia—Methotrexate—germ cell cancer	0.00101	0.00193	CcSEcCtD
Fosamprenavir—Pruritus—Methotrexate—germ cell cancer	0.000998	0.00191	CcSEcCtD
Fosamprenavir—Diarrhoea—Methotrexate—germ cell cancer	0.000965	0.00184	CcSEcCtD
Fosamprenavir—Dizziness—Methotrexate—germ cell cancer	0.000933	0.00178	CcSEcCtD
Fosamprenavir—Vomiting—Methotrexate—germ cell cancer	0.000897	0.00171	CcSEcCtD
Fosamprenavir—Rash—Methotrexate—germ cell cancer	0.000889	0.0017	CcSEcCtD
Fosamprenavir—Dermatitis—Methotrexate—germ cell cancer	0.000888	0.0017	CcSEcCtD
Fosamprenavir—Headache—Methotrexate—germ cell cancer	0.000883	0.00169	CcSEcCtD
Fosamprenavir—Nausea—Methotrexate—germ cell cancer	0.000838	0.0016	CcSEcCtD
